UK charity plans pioneering SCD (sudden cardiac death) genetic screening study:
This article was originally published in Clinica
The UK's leading charity devoted to reducing the incidence of sudden cardiac death (SCD) in young people is to assess the potential benefits of conducting population-wide genetic screening for the condition, Clinica has learnt. Cardiac Risk in the Young (CRY), in partnership with the University of Belfast, is to conduct a study based on the population of Northern Ireland. The results will then be extrapolated to the rest of the UK.
You may also be interested in...
A regulatory framework that encourages physicians to conduct experimental cell and gene therapies have propelled China to become a major developer of such promising cancer-treating tools, but insiders say three are a plethora issues at stake.
The first of around 260 patients for a clinical trial comparing its PB006 natalizumab biosimilar candidate to Biogen’s Tysabri reference brand have been recruited by Polpharma Biologics, which has just added Karsten Roth and Alexandra Moulson to its team.
How do notified bodies ensure that their personnel, and the teams they allocate for conformity assessment of medical devices, have the precise knowledge and expertise needed? A new EU document gives guidance on this.